Close

BIO Says Maine Price Control Law Will Hurt Patients, Stifle Biotech Innovation

May 12 2000
WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine law that ultimately will result in...

BIO Supportive of FDA Announcement on Biotech Policies

May 3 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s announcement regarding the agency’s...

XENOTRANSPLANTATION: The Benefits and Risks of Special Organ Transplantation

May 1 2000
A Position Paper fromThe Biotechnology Industry Organization

Executive Summary

1. Human organ transplantation faces a significant challenge because the need for this procedure far exceeds the...

BIO Testifies Proposed Rule On Confidentiality Of Patient Records Could Impede Research

Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton administration’s proposed rule for...

Gorton Bill Will Result In Price Controls, Hurting Seniors, Not Helping Them

Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to U.S. Sen. Slade Gorton’s (R-Wash.)...

BIO Leads Coalition In Support Of Full Funding Of U.S. Patent Office

Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full funding of the U.S. Patent and Trademark...

BIO Statement Regarding Congressional Report on the Safety of Agricultural Biotechnology

Apr 13 2000
WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who appeared before Congress during three...

BIO Encouraged By House GOP Drug Benefit Plan

Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued the following statement concerning...

BIO Statement Regarding National Research Council Press Release on Genetically Modified Plants

Apr 5 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to the National Research Council (NRC)...

BIO Supports Findings of National Research Council Report Regarding Genetically Modified Plants

Apr 5 2000
WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science and Regulation are well-founded in...